20-22 February, 2017

Biosimilars, Clinical Studies & Analytical Similarity Agenda

At the Biosimilars, Clinical Studies & Analytical Similarity Summit, we’ll be providing key insights from thought leaders into the biggest challenges in the analytical and clinical phases of biosimilar drug development, from responding to additional regulatory challenges, demonstrating the quality attributes needed to prove interchangeability, and successfully moving through the third phase of clinical trials.

For insight into speakers and sessions take a look at the 2016 agenda.

To receive a copy via email contact us at enquiryIQPC@iqpc.com with the subject line 'Biosimilars Agenda Request'

Please note: That all fields marked with an asterisk (*) are required.

First Name
Last Name
Job Title
Company Name
Email Address
Where did you hear about us?
If you’re a consultant, solution provider or technology provider and want to reach our senior level delegates tick here  
Yes, sign me up for the Pharma IQ e-newsletter, including information on Podcasts, Webinars, event discounts and online learning opportunities.